Medical/Pharmaceuticals

Concord Medical Reports Financial Results for the First Half of 2019

BEIJING, Aug. 23, 2019 /PRNewswire/ -- Concord Medical Services Holdings Limited ("Concord Medical" or the "Company") (NYSE: CCM), a specialty hospital management group and an operator of the network of radiotherapy and diagnostic imaging centers inChina, today announced its unaudited consolidate...

2019-08-24 06:00 294

CStone announces data from trials of CS1001, CS1002 and CS1003 to be released for the first time at 2019 CSCO Annual Meeting

SUZHOU, China, Aug. 23, 2019 /PRNewswire/ -- CStone Pharmaceuticals ("CStone" or the "Company", HKEX: 2616) today announced that the 22nd Annual Meeting of the Chinese Society of Clinical Oncology (CSCO, 2019 CSCO Annual Meeting) has accepted three abstracts on the clinical trials of CS1001 (Anti...

2019-08-23 11:26 434

CStone completes registration filing for the Phase I trial of CDK4/6 inhibitor CS3002 in Australia and will soon initiate the study

SUZHOU, China, Aug. 23, 2019 /PRNewswire/ --  CStone Pharmaceuticals ("CStone" or the "Company", HKEX: 2616) today announced that the Company has recently received ethics approval from the Human Research Ethics Committee inAustralia for the Phase I clinical trial of CS3002, andAustralia's Therape...

2019-08-23 11:20 432

New IDTechEx Report Shows Wearables Are Now Worth Over $50bn Per Year as Growth Quietly Continues

BOSTON, Aug. 23, 2019 /PRNewswire/ -- IDTechEx's latest report on the topic has found that wearable technology products will be worth over$50bn in 2019. In fact, the total market size has doubled in size since 2014, placing wearables as one of the most consistently successful markets around consu...

2019-08-23 10:00 453

Gencurix's Study Explores the Difference between GenesWell BCT and Oncotype DX

SEOUL, South Korea, Aug. 23, 2019 /PRNewswire/ -- Gencurix, Inc., a molecular diagnostics company, announced the publication of a new study onFrontiers in Oncology comparing GenesWell(TM) BCT, a prognostic multigene test, with Genomic Health's Oncotype DX in patients with early-stage breast cance...

2019-08-23 08:00 434

MCRA Hires Reimbursement Leader Tonya N. Dowd, MPH, as Vice President of Reimbursement, Health Economics, and Market Access

WASHINGTON, Aug. 23, 2019 /PRNewswire/ -- MCRA, LLC (www.mcra.com), a leading medical device advisory firm and Clinical Research Organization (CRO) integrating US and international regulatory, clinical research, reimbursement, healthcare compliance, and quality assurance, is pleased to announce a...

2019-08-23 08:00 468

Voronoi selects CDD Vault platform to manage its Drug Discovery Data

INCHEON, South Korea and SAN FRANCISCO, Aug. 23, 2019 /PRNewswire/ -- Voronoi, a drug discovery and development biotech company in Korea announced today that it has, after an extensive evaluation process, selected CDD Vault as its platform of choice to manage its drug discovery data and collabora...

2019-08-23 06:36 499

Regulation Needs to Keep Pace With Global Cannabis Legalisation in 2019 - Prohibition Partners

LONDON, Aug. 22, 2019 /PRNewswire/ -- The number of countries to legalise medical cannabis has risen nine-fold in the last five years, as global attitudes towards cannabis have shifted in favour of liberalisation. In 2019, 43 countries have legalised medical cannabis, with a host more allowing p...

2019-08-22 19:54 491

Luye Pharma's Investigational Drug Ansofaxine Hydrochloride Extended Release Tablets to Start Clinical Trials in Japan

TOKYO, Aug. 22, 2019 /PRNewswire/ -- Luye Pharma Group has announced its submission of the clinical trials application for a new chemical drug, Ansofaxine Hydrochloride Extended Release Tablets (LY03005) for the treatment of depression inJapan, with the trials expected to begin soon. Meanwhile, p...

2019-08-22 15:36 492

Innovent Enters a Licensing Agreement with Lilly to Develop & Commercialize a Novel Diabetes Medicine in China

SUZHOU, China, Aug. 22, 2019 /PRNewswire/ -- Innovent Biologics, Inc. (Innovent) (HKEX: 01801), a world-class biopharmaceutical company that develops and commercializes high quality medicines, today announced that it has entered into a licensing agreement with Eli Lilly and Company (Lilly) for th...

2019-08-22 07:30 597

Super Antioxidant Ergothioneine Achieves GRAS Status from FDA

Decision Drives Anti-Aging Market Emerging Studies Reveal Ergothioneine consumption is Correlated to Reducing Mild Cognitive Impairment RANCHO SANTA MARGARITA, California, Aug. 22, 2019 /PRNewswire/ -- Southern California-based ingredient supplier and manufacturer, Blue California announced th...

2019-08-22 04:50 601

Pneuma Respiratory, Inc. Announces New Chairman of the Board

BOONE, North Carolina, Aug. 22, 2019 /PRNewswire/ -- Pneuma Respiratory, Inc. announced that Board memberJay Morgan has assumed the position of Chairman of the Board. Pneuma's previous Chairman,Walt Robb, will remain a member of the Board of Directors. Jay Morgan served as VP Global Innovation a...

2019-08-22 03:17 595

Biotech Conagen Acquires Production Platform of Therapeutic Proteins

The technology should reduce costs to patients and accelerate drug development   BEDFORD, Massachusetts, Aug. 22, 2019 /PRNewswire/ -- Conagen, a vertically integrated synthetic biology company located inBoston's biotech corridor, announced today that it has acquired a fermentation-based technolo...

2019-08-22 01:39 611

CMAB and Kintor Announce a New Comprehensive Collaboration to Develop and Manufacture the ALK-1 Monoclonal Antibody

* This agreement represents the first strategic cooperation between two of the key players in biopharmaceutical industries in Suzhou,China * ALK-1 (Activin receptor-like kinase-1) antibody was originally developed by Pfizer who completed two Phase I clinical trials in more than 100 patients wi...

2019-08-21 21:35 1256

Global Cord Blood Corporation to Report First Quarter Fiscal 2020 Financial Results

HONG KONG, Aug. 21, 2019 /PRNewswire/ -- Global Cord Blood Corporation (NYSE: CO) (the "Company") today announced that it plans to release financial results for the first quarter fiscal 2020 onTuesday, August 27, 2019, after the market close.  The Company will host a conference call at 8:00 a.m....

2019-08-21 19:00 2514

NeuroVive Pharmaceutical AB Interim Report January - June 2019

STOCKHOLM, Aug. 21, 2019 /PRNewswire/ -- Important events April - June * The US Food and Drug Administration, FDA, approves NeuroVive's IND (Investigational New Drug) application, enabling clinical studies in the US with the company's drug candidate NeuroSTAT. * The Supreme Court delivers it...

2019-08-21 15:24 2626

Clinical Decision Support Systems Revolutionize the EMR to Become the Leader for Patient Empowerment

SANTA CLARA, California, Aug. 20, 2019 /PRNewswire/ -- Clinical decision support systems (CDSS) are poised to become the user interface of choice for clinical interactions with health IT, ultimately supplanting theelectronic health record (EHR) system as the primary health IT point of interface f...

2019-08-20 22:36 672

CStone submits an abstract on CS1001-201 trial to 2019 ASH Annual Meeting

SUZHOU, China, Aug. 20, 2019 /PRNewswire/ -- CStone Pharmaceuticals ("CStone", HKEX: 2616) today announced that an abstract on the company's CS1001-201 trial has been submitted to the upcoming 2019 American Society of Hematology (ASH) Annual Meeting. This will mark the first release of CS1001-201...

2019-08-20 10:18 3155

China SXT Pharmaceuticals, Inc. Announces Filing of Annual Report on Form 20-F for Year Ended March 31, 2019

TAIZHOU, China, Aug. 19, 2019 /PR Newswire/ -- China SXT Pharmaceuticals, Inc. (NASDAQ: SXTC) ("China SXT" or the "Company"), a specialty pharmaceutical company focusing on the research, development, manufacturing, marketing, and sales of Traditional Chinese Medicine Pieces ("TCMPs"), today annou...

2019-08-19 20:00 4059

Merck Granted Seven Additional CRISPR Patents, Bringing Total to 20 Worldwide

DARMSTADT, Germany, Aug. 19, 2019 /PRNewswire/ -- Merck, a leading science and technology company, today announced that the European, Israeli, South Korean and U.K. intellectual property offices have issued formal notices allowing seven additional Merck patent application claims covering CRISPR g...

2019-08-19 20:00 820
12345 ... 339